File(s) under permanent embargo
The integrative management of treatment-resistant depression: a comprehensive review and perspectives.
journal contribution
posted on 2014-03-01, 00:00 authored by A F Carvalho, Michael BerkMichael Berk, T N Hyphantis, R S McIntyreMajor depressive disorder is a prevalent and disabling illness. Notwithstanding numerous advances in the pharmacological treatment of depression, approximately 70% of patients do not remit after first-line antidepressant treatment.
History
Journal
Psychotherapy and psychosomaticsVolume
83Issue
2Pagination
70 - 88Publisher
KargerLocation
Basel, SwitzerlandPublisher DOI
eISSN
1423-0348Language
engPublication classification
C Journal article; C1 Refereed article in a scholarly journalCopyright notice
2014, KargerUsage metrics
Read the peer-reviewed publication
Categories
Keywords
Antidepressive AgentsAntidepressive Agents, Second-GenerationCognitive TherapyCombined Modality TherapyDepressive Disorder, Treatment-ResistantDrug SubstitutionHumansTreatment OutcomeScience & TechnologySocial SciencesLife Sciences & BiomedicinePsychiatryPsychologyTreatment-resistant depressionAugmentationLithiumSwitchingCombinationTriiodothyronineAtypical antipsychoticsSEROTONIN REUPTAKE INHIBITORSPLACEBO-CONTROLLED TRIALATYPICAL ANTIPSYCHOTIC MEDICATIONSVENLAFAXINE EXTENDED-RELEASED-ASPARTATE ANTAGONISTDOUBLE-BLINDMAJOR DEPRESSIONADJUNCTIVE THERAPYPINDOLOL AUGMENTATIONOLANZAPINE\/FLUOXETINE COMBINATION